| human | Q5 |
| P734 | family name | Rossi | Q8140765 |
| Rossi | Q8140765 | ||
| Rossi | Q8140765 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| Q28729772 | A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine |
| Q28954709 | A chikungunya fever vaccine utilizing an insect-specific virus platform |
| Q29352360 | A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models |
| Q41689803 | A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage |
| Q40475331 | Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. |
| Q47558649 | Age and Gender in the Zika Pandemic Era. |
| Q24261403 | An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors |
| Q34264257 | Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein |
| Q52671193 | Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models. |
| Q30240191 | Development of Vaccines for Chikungunya Fever |
| Q55084350 | Did Zika Virus Mutate to Cause Severe Outbreaks? |
| Q28804095 | Differential Responses of Human Fetal Brain Neural Stem Cells to Zika Virus Infection |
| Q38156637 | Differential Vector Competency of Aedes albopictus Populations from the Americas for Zika Virus |
| Q27481032 | Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon Production |
| Q36756643 | Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity |
| Q28595385 | Engineered Aedes aegypti JAK/STAT Pathway-Mediated Immunity to Dengue Virus |
| Q33911897 | Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice |
| Q45324156 | Experimental Zika Virus Infection of Neotropical Primates |
| Q24276430 | Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate |
| Q26864533 | Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus |
| Q59793774 | Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA |
| Q43046946 | Functional Analysis of Glycosylation of Zika Virus Envelope Protein |
| Q30145663 | Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential |
| Q35644626 | IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge |
| Q37156478 | IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice |
| Q34723422 | IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety |
| Q39411421 | Insect-Specific Viruses: A Historical Overview and Recent Developments |
| Q21245145 | Mesoniviruses are mosquito-specific viruses with extensive geographic distribution and host range |
| Q26247307 | Modeling Zika Virus Infection in Mice |
| Q27488421 | Mosquitoes Put the Brake on Arbovirus Evolution: Experimental Evolution Reveals Slower Mutation Accumulation in Mosquito Than Vertebrate Cells |
| Q40154937 | Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo |
| Q34518777 | Negevirus: a proposed new taxon of insect-specific viruses with wide geographic distribution |
| Q40056614 | Outbreak of Zika Virus Infection, Chiapas State, Mexico, 2015, and First Confirmed Transmission by Aedes aegypti Mosquitoes in the Americas |
| Q43046627 | Outcomes of Congenital Zika Disease Depend on Timing of Infection and Maternal-Fetal Interferon Action |
| Q24276417 | The role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infection |
| Q28735954 | Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis |
| Q38157833 | Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease |
| Q29365410 | Variation in Aedes aegypti Mosquito Competence for Zika Virus Transmission |
| Q38156739 | Viral Retinopathy in Experimental Models of Zika Infection |
| Q56932479 | West Nile virus |
| Q59245613 | ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in Viremic Cynomolgus Macaques |
| Q40051335 | Zika Virus Vector Competency of Mosquitoes, Gulf Coast, United States |
| Q30402859 | Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network |
| Q47547783 | Zika virus infection elicits auto-antibodies to C1q. |
Search more.